InvestorsHub Logo
Followers 16
Posts 1063
Boards Moderated 0
Alias Born 09/01/2019

Re: medchem post# 11847

Saturday, 10/17/2020 2:45:45 PM

Saturday, October 17, 2020 2:45:45 PM

Post# of 16706
I realize my limitations as I am just an investor attempting to put up links and comments to stimulate conversations so I can learn too. Glad to have you back with your accepted knowledge to refine stuff. Good to hear you're healthy, I / we were worried.

I said, I 'hope' Dr Williams has some comments. Another 'popular' drug in similar Phase 2b Trials has had their leaders give semi-supported guidance from an uncompleted Phase 2b Trial and I didn't want that. I thought it might be common to give a general "we have confidence in the current Trial Data" kind of thing 'AFTER' last patient is enrolled/dosed. I agree REAL DATA is found on the CT.Gov site, all else is opinions from ('dudes') or unsubstantiated questionable hype/bash.

Thanks for also confirming that a Phase 2b Trial with success moves to a Real Life Phase 3 for statistical significance.
Maybe the 'Rights'(?) might be sold to a Biggie Pharma or maybe a partnership, using them to continue with further Trials and for marketing/production after a COMPLETED Phase 2b CT has significant enough Data.?.

AGN doesn't carry the 'big stick' to push things thru like a Big Pharma might do and can more easily afford.
Your opinions, evaluations and inputs were missed and appreciated...GLTA...